시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
분자 세포 유전학 시장 규모, 점유율, 성장 분석 : 제품별, 기술별, 용도별, 최종사용자별, 지역별 - 산업별 예측(2024-2031년)
Molecular Cytogenetics Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Testing Kits), By Technique (Comparative Genomic Hybridization), By Application, By End User, By Region - Industry Forecast 2024-2031
상품코드 : 1619169
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 242 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,606,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,898,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,189,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 분자 세포 유전학 시장 규모는 2022년에 23억 7,000만 달러로 평가되며, 2023년 25억 8,000만 달러에서 2031년에는 50억 2,000만 달러로 성장하며, 예측 기간 중(2024-2031년)에 CAGR 8.7%로 성장할 전망입니다.

분자생물학과 세포 유전학을 통합한 분자 세포 유전학 분야는 정상적인 인간 세포에는 46개의 염색체가 존재한다는 기초 지식을 바탕으로 건강한 세포와 암세포를 구별하는 데 중요한 역할을 합니다. 이 분야는 형광 in situ hybridization(FISH)과 같은 기술을 통해 염색체 이상에 초점을 맞추고 뇌종양 및 혈액 악성 종양을 포함한 다양한 암을 감지하고 치료하는 데 도움을 줍니다. 이 시장은 암 유병률 증가, 유전성 질환, 고령화 등으로 인해 상당한 성장세를 보이고 있습니다. 또한 표적 치료의 보급과 시약 및 소프트웨어 개선을 포함한 의료 기술의 발전은 진단 정확도 향상에 기여하고 있습니다. 생물 의학 연구에 대한 투자 증가는 시장 확대를 더욱 촉진하고, 분자 세포 유전학의 탄탄한 미래를 예측했습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

분자 세포 유전학 시장 규모 : 제품별

분자 세포 유전학 시장 규모 : 기술별

분자 세포 유전학 시장 규모 : 용도별

분자 세포 유전학 시장 규모 : 최종사용자별

분자 세포 유전학 시장 규모 : 지역별

경쟁 정보

주요 기업 개요

결론과 권장사항

KSA
영문 목차

영문목차

Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

The field of molecular cytogenetics, integrating molecular biology and cytogenetics, plays a crucial role in distinguishing healthy cells from cancerous ones, stemming from the foundational knowledge that normal human cells contain 46 chromosomes. This discipline aids in the detection and treatment of various cancers, including brain tumors and hematological malignancies, focusing on chromosomal abnormalities through techniques like fluorescence in situ hybridization (FISH). The market is witnessing significant growth, driven by the increasing prevalence of cancer, genetic disorders, and an aging population. Additionally, the rising adoption of targeted therapies and advancements in healthcare technology, including improved reagents and software, contribute to enhanced diagnostic accuracy. Increased investment in biomedical research further propels market expansion, projecting a robust future for molecular cytogenetics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Molecular Cytogenetics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Molecular Cytogenetics Market Segmental Analysis

Global Molecular Cytogenetics Market is segmented by product, technique, application, end user and region. Based on product, the market is segmented into kits & reagents, instruments, consumables and software & services. Based on technique, the market is segmented into comparative genomic hybridization, fluorescence in-situ hybridization, chromogenic in-situ hybridization, karyotyping and other techniques. Based on application, the market is segmented into genetic disorders, cancer, personalized medicine and other applications. Based on end user, the market is segmented into clinical & research laboratories, hospitals & path labs, academic research institutes, pharmaceutical & biotechnology companies and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is poised for significant growth, driven primarily by the rising incidence of cancer cases worldwide. This field, which merges the principles of cytogenetics with molecular biology, is expected to see increased adoption as more healthcare professionals recognize its efficacy in diagnosing and understanding various cancers. The growing prevalence of cancer not only highlights the need for advanced diagnostic tools but also encourages investments and research in molecular cytogenetics, thereby fueling market expansion. As a result, the demand for molecular cytogenetics will likely continue to rise throughout the projected period.

Restraints in the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market faces several significant constraints that could impede its growth. Stringent regulatory requirements pose a challenge, as compliance can be both complex and time-consuming. Additionally, unfavorable reimbursement policies from insurance providers significantly limit access to molecular diagnostic tests, which are essential for early detection of genetic conditions. The high costs associated with these tests, typically ranging around USD 300 each, also create a financial barrier for many patients and healthcare providers. Collectively, these factors contribute to a restrictive environment that hampers the expansion of the molecular cytogenetics market.

Market Trends of the Global Molecular Cytogenetics Market

The Global Molecular Cytogenetics market is witnessing a robust growth trend, driven primarily by the increasing emphasis on personalized medicine and advanced therapeutic options in oncology. As genomic understanding becomes crucial for effective cancer care-enabling precise diagnostics, tailored treatment plans, and improved survival predictions-the demand for molecular cytogenetic techniques is surging. This market is expected to expand significantly as healthcare providers leverage these technologies for detailed cancer analysis and individualized therapies. As pharmacotherapy and bespoke treatment alternatives gain prominence, the market is poised for lucrative expansion throughout the forecast period, underlining the pivotal role of molecular cytogenetics in modern oncology.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Molecular Cytogenetics Market Size by Product & CAGR (2024-2031)

Global Molecular Cytogenetics Market Size by Technique & CAGR (2024-2031)

Global Molecular Cytogenetics Market Size by Application & CAGR (2024-2031)

Global Molecular Cytogenetics Market Size by End User & CAGR (2024-2031)

Global Molecular Cytogenetics Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기